Koen J P Verhees

Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.

M. Kelders, A. Schols, J. L. van der Velden, 2011, American journal of physiology. Cell physiology.

Glycogen synthase kinase-3 (cid:1) is required for the induction of skeletal muscle atrophy

M. Kelders, A. Schols, R. Langen, 2011 .

Recovery of muscle mass and muscle oxidative phenotype following disuse does not require GSK-3 inactivation.

M. Kelders, A. Schols, C. de Theije, 2020, Biochimica et biophysica acta. Molecular basis of disease.

Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.

M. Kelders, A. Schols, C. de Theije, 2015, Biochimica et biophysica acta.

Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study

J. Deharo, N. Clementy, L. Lamarsalle, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Pacemaker complications and costs: a nationwide economic study

J. Deharo, N. Clementy, L. Lamarsalle, 2019, Journal of medical economics.

Regulation of skeletal muscle plasticity by glycogen synthase kinase-3β: a potential target for the treatment of muscle wasting.

A. Schols, R. Langen, K. Verhees, 2013, Current pharmaceutical design.

Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism.

A. Schols, R. Langen, H. Gosker, 2017, Biochimica et biophysica acta. Molecular basis of disease.

TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.

A. Schols, R. Langen, H. Gosker, 2015, Endocrinology.

Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy

H. Baarsma, A. Schols, R. Gosens, 2013, Respiratory Research.

Real‐world geographic variations in the use of cardiac implantable electronic devices—The PANORAMA 2 observational cohort study

I. Ebrahim, D. Bastian, V. Kuznetsov, 2018, Pacing and clinical electrophysiology : PACE.

Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study

A. Curtis, E. Chung, M. G. St. John Sutton, 2019, Journal of medical economics.